CXR BIOSCIENCES
DEAD

Serial Number

78131369

Owner

CXR Biosciences Limited

Attorney

Martha Gayle Barber

Filing Date

May 28, 2002

Add to watchlist:

No watchlists yet
View on USPTO

CXR BIOSCIENCES Trademark

Serial Number: 78131369 • Registration: 2791110

CXR BIOSCIENCES is a trademark filed by CXR Biosciences Limited on May 28, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

CXR Biosciences Limited

2 James Lindsay Place
Dundee, DD1 5JJ , GB

Entity Type: 03

Trademark Details

Filing Date

May 28, 2002

Registration Date

December 9, 2003

Published for Opposition

September 16, 2003

Cancellation Date

June 21, 2024

Goods & Services

[APPARATUS FOR CARRYING OUT ASSAYS, NAMELY, CHROMATOGRAPHY APPARATUS, ELECTROPHORESIS APPARATUS, SPECTROSCOPY APPARATUS, MICROARRAYS AND TISSUE CULTURE APPARATUS; APPARATUS FOR SCIENTIFIC USE, NAMELY, CHROMATOGRAPHY APPARATUS, ELECTROPHORESIS APPARATUS, SPECTROSCOPY APPARATUS, MICROARRAYS, TISSUE CULTURE APPARATUS AND BIOREACTORS; APPARATUS FOR RESEARCH PURPOSES, namely, CHROMATOGRAPHY APPARATUS, ELECTROPHORESIS APPARATUS, SPECTROSCOPY APPARATUS, MICROARRAYS AND TISSUE CULTURE APPARATUS, DIAGNOSTIC APPARATUS FOR SCIENTIFIC USE, NAMELY, CHROMATOGRAPHY APPARATUS; DIAGNOSTIC APPARATUS FOR SCIENTIFIC USE, NAMELY, CHROMATOGRAPHY APPARATUS; ELECTROPHORESIS APPARATUS, SPECTROSCOPY APPARATUS, MICROARRAYS AND TISSUE CULTURE APPARATUS; AND ELECTROPHORESIS APPARATUS, SPECTROSCOPY APPARATUS, MICROARRAYS AND TISSUE CULTURE APPARATUS]

[BIOCHEMICAL PREPARATIONS FOR MEDICAL USE IN THE NATURE OF [ANTIBODIES, INTERFERONS,] PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES; BIOTECHNOLOGICAL PREPARATIONS FOR VETERINARY USE IN THE NATURE OF [ANTIBODIES, INTERFERONS,] PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES; CHEMICAL OR BIOCHEMICAL OR BIOCHEMICAL PRODUCTS FOR MEDICAL OR VETERINARY PURPOSES OR RESEARCH IN THE NATURE OF [ANTIBODIES, INTERFERONS,] PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES; [CLINICAL DIAGNOSTIC REAGENTS;] MEDICAL AND VETERINARY REAGENTS FOR MEDICAL LABORATORY USE; BIOACTIVE SUBSTANCES OBTAINED FROM ANIMALS OR BY SYNTHESIS, NAMELY[ ANTIBODIES, INTERFERONS,] PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES; AND BIOLOGICAL SUBSTANCES FOR MEDICAL USE, namely, [ANTIBODIES, INTERFERONS,] PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES]

CHEMICAL OR BIOCHEMICAL PRODUCTS FOR RESEARCH PURPOSES, NAMELY, [ANTIBODIES, INTERFERONS,] [PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES; CHEMICALS OR BIOCHEMICALS FOR BIOTECHNOLOGICAL RESEARCH, NAMELY,] [ANTIBODIES, INTERFERONS,] [PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES; CHEMICALS OR BIOCHEMICALS FOR USE IN SCIENTIFIC RESEARCH, NAMELY,] [ANTIBODIES, INTERFERONS,] [PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES;] [ DIAGNOSTIC PREPARATIONS, OTHER THAN FOR MEDICAL OR VETERINARY USE, NAMELY, ][ANTIBODIES, INTERFERONS,] [PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES;] [REAGENTS FOR IN VITRO OR IN VIVO USE, OTHER THAN FOR MEDICAL USE; CHEMICAL OR BIOCHEMICALS FOR USE IN THE MANUFACTURE OF DRUGS, NAMELY,] [ANTIBODIES, INTERFERONS,] [PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES;] BIOLOGICAL PREPARATIONS FOR LABORATORY PURPOSES OR FOR SCIENTIFIC PURPOSES, NAMELY, [ANTIBODIES, INTERFERONS,] PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES; AND SUBSTANCES PRODUCED BY CHEMICAL ENGINEERING, BUT NOT FOR MEDICAL USE, NAMELY,[ ANTIBODIES, INTERFERONS,] PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE AND POLYPEPTIDES

Biotechnological research; scientific research; services for assessing the safety or efficiency of medical, veterinary or scientific research drugs; medical research; consultancy services relating to the development of dental, medical and scientific products; advisory services relating to the design of safety programs; advisory and consultancy services relating to scientific, medical and veterinary regulatory procedures and requirements

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jun 21, 2024 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 9, 2022 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Dec 2, 2013 NAS8
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Dec 2, 2013 RNL1
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
Dec 2, 2013 9G8P
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
Dec 2, 2013 8PRT
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Nov 18, 2013 89AF
TEAS SECTION 8 & 9 RECEIVED
Nov 18, 2013 E89R
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 8, 2010 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 5, 2010 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Dec 28, 2009 815F
TEAS SECTION 8 & 15 RECEIVED
Dec 28, 2009 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 10, 2008 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 10, 2008 TCCA
REGISTERED-PRINCIPAL REGISTER
Dec 9, 2003 R.PR
PUBLISHED FOR OPPOSITION
Sep 16, 2003 PUBO
NOTICE OF PUBLICATION
Aug 27, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 23, 2003 CNSA
CASE FILE IN TICRS
Jul 21, 2003 CFIT
Sec. 1(B) CLAIM DELETED
Jul 2, 2003 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2003 CRFA
PAPER RECEIVED
Jul 2, 2003 MAIL
LETTER OF SUSPENSION E-MAILED
May 1, 2003 GNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 21, 2003 CRFA
PAPER RECEIVED
Mar 21, 2003 MAIL
NON-FINAL ACTION E-MAILED
Sep 21, 2002 GNRT
ASSIGNED TO EXAMINER
Sep 20, 2002 DOCK